Pharma
ZS, a renowned management consulting and technology firm, is embarking on a new phase of growth with the introduction of a specialized business unit focusing on its successful cloud-based platforms and products. The initiative reflects the company's sustained client engagement and its strategic investment in software-as-a-service (SaaS) over the past decade, leading to significant advancements in sectors ranging from life sciences to hospitality. According to forecasts by Fortune Business Insights, the SaaS market is poised for explosive growth, anticipated to increase from $237.48 billion in 2022 to $908.21 billion by 2030.
To steer this ambitious endeavor, ZS has appointed its Chairman, Jaideep Bajaj, as the head of the new business unit. This move is aligned with ZS's goal to integrate its platforms and products more deeply into its growth strategy.
“ZS clients are facing a wide array of business challenges. While platforms and products are not new to ZS, the creation of this new business unit will allow us to better serve clients with complementary, world-class product and consulting services. Through both our historic consulting services and technology offerings, we’ll continue to help companies realize their digital operating models, drive business transformation and respond to changing market needs by using ZS’s AI-powered, globally applicable, self-serve technologies.”- Jaideep Bajaj
